You are here: Industry Insights > API

News List

Meeting global quality standards: A look at CNS & cardiovascular APIs Suzanne Elvidge
August 22, 2025
Active pharmaceutical ingredients (APIs) are the active ingredients used in pharmaceutical manufacturing and are formulated with excipients to create the finished drug form.
API Cost Inflation and Tariffs – What Pharma Buyers Must Know in 2025 Saher Haider
July 25, 2025
From surging raw material prices to looming tariffs on imported APIs, pharmaceutical buyers in 2025 are undergoing inflationary pressure from every corner.
Pharma Sources Insight July 2025: GLOBAL API SOURCING TRENDS Pharma Sources Insight
July 11, 2025
Pharma Sources Insight July 2025 focuses on global API sourcing trends and more.
Small Molecule Drugs for Obesity: A Scalable, Oral Alternative to Peptide-Based Therapies Neeta Ratanghayra
August 22, 2025
Obesity remains one of the most pressing public health crises of the current time. Beyond the difficulty of achieving weight loss, long-term weight maintenance remains a major hurdle - data shows that up to 80% of lost weight is regained within five years
Synthetic vs. Natural APIs: Key Considerations for Pharmaceutical Manufacturers Nurah Ali
June 13, 2025
Synthetic APIs?? offer high purity, cost efficiency, and oral stability, while ??natural APIs?? face variability and cold-chain challenges. Key trade-offs impact scalability and regulatory compliance.
Global API Sourcing Trends: Why Quality Antibiotics Matter in 2025 Saher Haider
August 22, 2025
Quality antibiotic APIs?? are critical to combat ??antimicrobial resistance (AMR)??. Global buyers prioritize ??GMP-compliant suppliers?? (notably Chinese exporters) for ??resilient sourcing?? amid regulatory and ESG pressures in 2025.
Beyond Antibiotics: The Expanding Role of Anti-Infective APIs in Bacterial Infection Suzanne Elvidge
June 13, 2025
Beyond antibiotics??, novel anti-infective approaches include ??AMPs?? targeting biofilms, ??FMT capsules?? ,nanoparticle delivery systems??, and ??synbiotics?? to combat the global ??AMR crisis??.
Another BlockBuster in HKEX18A Biotech Companies: IPO of DualityBio in Hong Kong, Introducing New Capital Engine in the ADC Field? Kevin
April 15, 2025
On April 15, DualityBio, a rising star in the ADC field, was officially listed on the HKEX, marking one of the most high-profile IPOs in recent years in Chapter 18A Biotech Companies.
API Registration Process in Pakistan Saher Haider
April 07, 2025
APIs are the biologically active components in pharmaceutical drugs responsible for producing the intended therapeutic effects.
Pharma Sources Insight January 2025: What are Reshaping Pharma's Future? Pharma Sources Insight
January 09, 2025
Pharma Sources Insight JUNE 2024 focuses on wearable delivery system, sythetic biology, pharmaceutical globalization and more.